Amylases

Amylases are crucial enzymes which hydrolyze internal glycosidic linkages in starch and produce as primary products dextrins and oligosaccharides. Amylases are classified into α-amylase, β-amylase, and glucoamylase based on their three-dimensional structures, reaction mechanisms, and amino acid sequences. Amylases have innumerable applications in clinical, medical, and analytical chemistries as well as in food, detergent, textile, brewing, and distilling industries.

Amylases Related Products (69):

By Effects:	Inhibitors (56) Substrates (2) Agonist (1)

Cat. No.	Product Name	Effect	Purity	Chemical Structure

HY-161429

Antidiabetic agent 5	Inhibitor
Antidiabetic agent 5 (compound S1) is a antidiabetic agent. Antidiabetic agent 5 inhibits the activity of α-glucosidase and α-amylase with IC₅₀ values of 3.91，8.89 μM，respectively. Antidiabetic agent 5 decreases sugar levels. Antidiabetic agent 5 has the potential for the research of type-II diabetes.

HY-133718

Acarviosin
Acarviosin, a pseudodisaccharide moiety, is a part of the potent inhibitor of α-amylase.

HY-N0668R

Rubusoside (Standard)	Inhibitor
Rubusoside (Standard) is the analytical standard of Rubusoside. This product is intended for research and analytical applications. Rubusoside is a diterpene glycoside that is also a sweetener and solubilizer with anti-angiogenic, anti-cancer, anti-obesity, anti-allergic and anti-asthmatic effects. Rubusoside attenuates airway hyperresponsiveness and reduces inflammatory cells in bronchoalveolar lavage fluid (BALF), reducing OVA (HY-W250978)-induced airway inflammation. Rubusoside also prevents palmitic acid-induced lipotoxicity in pancreatic INS-1 cells, reduces the transport of human glucose transporters GLUT-1 and fructose GLUT-5, and inhibits NF-κB and α-amylase (α-amylase).

HY-N14506

Gibbestatin B	Inhibitor
Gibbestatin B inhibits the expression of α-amylase induced by gibberellin in De-embryoned rice and barley (IC₅₀ is 25-50 ppm), and has no anti-bacterial, anti-yeast and anti-fungal effects at 100 ppm.

HY-113159A

Docosapentaenoic acid (22n-3) sodium	Inhibitor
Docosapentaenoic acid (22n-3) sodium is a component of phospholipids. Docosapentaenoic acid 22n-3 sodium has inhibitory activity against α-amylase and α-glucosidase, with IC₅₀s value of 17 μg/mL and 22 μg/mL, respectively. Docosapentaenoic acid 22n-3 sodium increases cell vitality. Docosapentaenoic acid 22n-3 sodium has a weak anti-inflammatory effect.

HY-170796

α-Amylase-IN-11	Inhibitor
α-Amylase-IN-11 (compound C5f) is an α-Amylase inhibitor (IC₅₀=0.56 μM) that can reduce the sugar level in vivo. α-Amylase-IN-11 has a moderate inhibitory effect on α-glucosidase (α-glucosidase), with IC₅₀=11.03 μM. α-Amylase-IN-11 can significantly reduce the glucose concentration in a mouse model and has the potential for use in diabetes research.

HY-170548

α-Amylase-IN-10	Inhibitor
α-Amylase-IN-10 (Compound 15n) is an inhibitor for α-Amylase with an IC₅₀ of 5.00 µM. α-Amylase-IN-10 can be used for research of type 2 diabetes mellitus.

HY-162635

α-Amylase/α-Glucosidase-IN-14	Inhibitor
α-Amylase/α-Glucosidase-IN-14 (compound 6E) is an oral bioactive inhibitor of α-amylase and α-glucosidase, with the IC₅₀s of 45.53 μM and 27.73 μM, respectively.

HY-161782

α-Amylase-IN-7	Inhibitor
α-Amylase-IN-7 (Compound 6e) is an inhibitor for α-Amylase with an IC₅₀ of 40 μM. α-Amylase-IN-7 exhibits potential as an antidiabetic agent.

Name
Email *

	Sorry, but the email address you supplied was invalid.